Anagenex is building a novel platform for drug discovery focusing on difficult targets.

Anagenex's technology analyzes 100-1000x more compounds compared to traditional approaches by combining machine learning with DNA Encoded Libraries.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2020

• Founders

  • Nicolas Tilmans, PhD
  • Zavain Dar

  LUX Partners

  • Shaq Vayda

• Latest Tweets

  • Thank you for telling our story @endpts and @PaulSchloesser! https://t.co/LKLgiHJVX9@anagenex - 03:29 PM Jun 8th
  • Thrilled to announce our Series A financing led by @CatalioCapital joined by @Lux_Capital, @khoslaventures,… https://t.co/HNuSPQvvB2@anagenex - 02:10 PM Jun 8th